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The biochemical nature of the T-cell antigen recognition structure and its relation- 
ship to serum antibody is still an important unresolved issue in immunology. Several 
independent lines of evidence indicate that  immunoglobulin V-region products are 
involved in the cell-surface T-cell receptor (I-5). Most of the evidence supporting this 
concept has been obtained by using anti-idiotypic antisera as probes to analyze the 
biological  and  biochemical  properties  of such  receptors.  The  present  experiments 
describe the influence of genes in the VH-region on the specificity of selected T-cell 
responses.  The  approach  taken  here  was  based  on  a  genetic  analysis  of the  fine 
specificity of the T-cell response to the (4-hydroxy-3-nitrophenyl)acetyl (NP)1 hapten. 
Recent work from several laboratories on the primary anti-NP antibody response has 
revealed the presence of genetic V-region markers in these anti-hapten antibodies by 
both anti-idiotypic and fine-specificity characterization (6-8). It was found that  the 
primary anti-NP antibody response in most mice of the Igl b allotype has a peculiar 
heteroclitic fine specificity (6), i.e., these antibodies bind an analogue of the immu- 
nizing  hapten,  (4-hydroxy-5-iodo-3-nitrophenyl)acetyl (NIP),  with  greater  affinity 
than the immunizing hapten, NP, itself. The primary anti-NP antibodies from such 
heteroclitic strains share common, strain-specific clonotypes as shown by isoelectric 
focusing (9).  Furthermore, two laboratories have prepared anti-idiotypic antibodies, 
one,  apparently combining site  specific,  as  evidenced by  the  ability  of hapten  to 
inhibit anti-idiotype binding of the idiotypic antibody, and the other, hapten nonin- 
hibitable  (7, 8).  Both of these anti-idiotypic reagents have been used  to identify at 
least one germ-line gene which maps  to the VH-region of Igl b heavy-chain linkage 
group.  This gene has  been  termed VHNP  b (7,  10).  The  idiotype-positive antibody 
comprises the predominant antibody population of the primary anti-NP response of 
C57BL/6 mice (>85%) and also ofF1 hybrid mice between C57BL/6 and an idiotype- 
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negative strain (8). Finally, the idiotype-positive antibody expresses the )~-light chain 
as its predominant light-chain species, and all detectable heterogeneity in the idiotype- 
positive population could be accounted for by the heterogeneity among the heavy 
chains (7, 8). SJL, despite producing Igl b allotype-positive antibody, has been shown 
to  produce  a  nonheteroclitic,  idiotype  negative,  primary  anti-NP  response.  The 
VHNP  b gene, however, is thought to be present in SJL, as is shown by the demonstra- 
tion of idiotype production in primary anti-NP response of Fx crosses  of SJL with 
nonheteroclitic strains,  (CBA  ×  SJL)F1 mice (7), or (BALb/c  ×  SJL)F1 mice (8). 
Thus, the primary anti-NP antibody response is associated with a characteristic fine- 
specificity marker, clonotype, h-light chain bearing immunoglobulin and idiotypic 
markers. 
These characteristics of the V-region markers of anti-NP antibodies have also been 
used  in  characterization  of NP-binding  receptor  material  isolated  from  enriched 
populations of NP-primed splenic B- and T-lymphocytes. Antigen-binding material 
was isolated by adsorption of NP-specific T  lymphocytes to hapten-conjugated nylon 
wool, followed by a temperature shift to release the cells, and elution of the receptor 
material with acidic buffer or free hapten. Amounts of receptor material isolated from 
C57BL/6  splenic  lymphocytes lacking  immunoglobulin C-region  determinants  of 
either heavy or light chains, correlated with the relative number of T  cells.  It was 
concluded that this material was of T-cell origin (11). Genetic analysis of the anti-NP 
responses of (C57BL  ×  CBA/J)F2 mice, indicated that the putative T-cell receptor 
material  was  heteroclitic  if,  and  only  if,  the  material  originated  from  animals 
expressing the Igl b allotype. Furthermore, an identical correlation was found between 
the heavy-chain allotype and the presence of the idiotype on this material. It was thus 
concluded that in this system the T-cell receptor for antigen bears identical VH-region 
markers as those found on immunoglobulin of the same specificity (11,  12). 
In addition to VH-region markers, another characteristic property oft  lymphocytes 
is their functional specificity for antigens of the major histocompatibility complex. 
The dual specificity of T cells indicates the contribution of the products of two distinct 
chromosomes to the functional specificity of T  cells and inspired the hypothesis by 
several investigators of two receptors on T  lymphocytes, one for the nominal antigen 
and the other for the major histocompatibility complex MHC-gene product. We felt 
that the study of a  functional T-cell response, such as hapten-specific delayed-type 
hypersensitivity in the NP-NIP system should provide information in the appropriate 
mouse strains on the expression of VH genes on T cells together with receptors specific 
for MHC-gene products. 
The experiments reported here establish the Vn-region control of the fine specificity 
of delayed-type hypersensitivity (DTH) against NP, the T-cell nature of this phenom- 
enon, and an independent MHC-linked restriction on the function of these T  cells. 
The  evidence presented  below  indicates that  at  least  two distinct genetic loci  are 
involved in determining the specificity of functional DTH T  cells. 
Materials and Methods 
Mice.  C57BL/6, BALB/c, (BALB/c  ×  C57BL/6)F1, (C57BL/6  ×  C3H)Fa, B10.A, A/J, 
B10.BR,  SJL,  and  C3HeB/FeJ  mice  were  purchased  from  The Jackson  Laboratory, Bar 
Harbor, Maine. C.B-20, BAB/14, B10.A(4R), B10.A(5R), and CBA(M523) mice were bred in 
the animal facilities of Harvard Medical School. Mice were used at 2-20 mo of age, and were 
maintained on laboratory chow and acidified, chlorinated water ad libitum. 1338  GENETIC CONTROL OF DELAYED-TYPE HYPERSENSITIVITY 
Antigens.  Two times  recrystallized NP-OSuccinamide and  NIP-OSuccinamide were pur- 
chased from Biosearch (San Rafael, Calif.).  NP and NIP conjugates of bovine serum albumin 
(BSA)  and bovine gamma globulin  (BGG) were prepared as follows.  BSA and BGG (Sigma 
Chemical Co., St.  Louis, Mo.) were dissolved in a pH 9.0, 0.2 M  NaHCO3-NaOH buffer, to 
achieve a final protein concentration of 20 mg/ml. The active succinamide dissolved in dioxane 
at  25  mg/ml  for NP  conjugates,  and  33  mg/ml  for  NIP conjugates  was  added  at  room 
temperature.  For each milliliter of carrier solution to be conjugated, 80 #! of the succinamide 
solution was added dropwise. The reaction was allowed to proceed for 18 h at 4°C, and the 
resulting compounds were dialyzed extensively against borate buffered saline,  pH 8.4. The final 
conjugation ratios were NPn-BSA, NP17-BGG, NIPo-BSA, and NIPls-BGG. 
Immunization and Challenge.  All animals described below, except adoptive transfer recipients, 
were pretreated with 20 mg/kg cyclophosphamide in 0.2 ml phosphate-buffered saline (PBS), 
injected i.p., 3 days before immunization. The NP-BGG or NIP-BGG antigens were emulsified 
in complete Freund's adjuvant (CFA) (Difco Laboratories, Detroit, Mich.) containing Mycobac- 
terium butyricum, so that the antigen concentration was 500 #g/ml of CFA emulsion. A total of 
0.2 ml of emulsion was injected subcutaneously bilaterally divided between two sites on the 
dorsal flanks.  Donors for adoptive transfer experiments received an additional two 0.1-ml s.c. 
injections near the forelimbs. 
7 d after immunization, mice were challenged for the DTH response by injecting, into the 
left footpad, 25 #1 of a solution containing  1 mg/ml NP-BSA or NIP-BSA in PBS, and was 
measured, using an engineer's micrometer, 24 h after challenge. Swelling was determined as the 
difference, in units of 10  -4 inches, between the left  footpad thickness and  the right footpad 
thickness.  All animals were measured by three  independent  observers, whose measurements 
were then averaged. 
Adoptive Transfer Experiments.  Draining lymph nodes from donors primed 7 d earlier,  were 
removed and a single-cell  suspension was prepared by gentle teasing in cold Eagle's minimum 
essential  medium.  These cells  were washed twice, counted, and  transferred  intravenously to 
naive recipients. 
In several experiments,  the cells to be transferred were twice treated with AKR anti-C3H 
antiserum (anti-Thy 1.2) and rabbit complement as previously described (13). 
Histology of Footpad Responses.  The feet of animals in which responses were elicited 7 d after 
immunization were removed and placed in buffered  10% formalin.  Hematoxylin and eosin- 
stained sections of the decalcified feet were prepared by Ms. M. Hagney of Harvard Medical 
School. 
Statistical Analysis.  Analysis of average differences of swelling obtained was performed with 
the Wang Programmable computer. The arithmetic means and SEM were expressed, as well 
as the relevant P value, obtained with the two tailed Student's t test.  In this paper, any result 
referred to as significant had a P value of <<0.01, the P value of nonsignificance was P >  0.05, 
unless indicated otherwise. 
Results 
Induction ofNP-Specific DTH Responses.  When animals were pretreated with 20 mg/ 
kg cyclophosphamide, followed 3 d  later by subcutaneous priming with  100 #g NP- 
BGG in CFA, NP-specific DTH  could be elicited  in response to challenge with  NP 
conjugated to a  heterologous carrier,  BSA. The DTH  response was characterized by 
a  delayed onset of footpad swelling which peaked at 20-36 h  and by a  mononuclear 
cell infiltrate  (data not shown). As shown in Table I, A/J, CBA(M523), BALB/c, and 
C3H mice which were classified as nonheteroclitic strains at the antibody level made 
NP-specifie DTH responses after priming with NP-BGG and challenge with NP-BSA. 
The specificity of these  responses  is  evidenced  by the  inability  of NP-BGG primed 
mice of the A/J, CBA(M523), BALB/c, and C3H strains to display significant levels 
of DTH  after  challenge  with  NIP-BSA. The  latter  findings  imply that  BSA is  not 
significantly cross-reactive with BGG, and that the DTH response is truly NP specific. WEINBERGER  ET  AL. 
TABLE  I 
The Cross-Reactivity  of NP with NIP in DTH Responses of Different Strains of Mice* 
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Strain  Heavy-chain  haplotype  Immunogen 
DTH challenge 
NP-BSA:~  NIP-BSA 
A/J  e  NP-BGG  45.0  -t- 2.9  8.8  ±  2.2 
NIP-BGG  NT  54.8  +  4.9 
CFA  13.8 4-  1.8  10.2 4- 3.8 
CBA(M523)  j  NP-BGG  32.6  4- 2.2  9.5  -4- 4.8 
NIP-BGG  NT  37.5  ±  2.1 
CFA  6.6  4- 2.7  5.6  +  2.8 
BALB/c  a  NP-BGG  68.5  ±  7.2  5.5  ±  3.3 
NIP-BGG  NT  60.5  ±  2.5 
CFA  8.0  4- 5.4  5.5  ±  3.7 
C3H  j  NP-BGG  87.0  4- 5.8  20.3 +  3.6 
NIP-BGG  NT  83.8  4- 5.4 
CFA  10.2 4-  1.4  16.0 ±  2.7 
C57BL/6  b  NP-BGG  82.0  ±  10.0  57.0  ±  5.8 
CFA  16.3 ±  5.5  5.0:1:3.9 
BI0.A  b  NP-BGG  67.0  ±  5.8  63.5  4-  1.6 
NIP-BGG  NT  56.0  ±  2.6 
CFA  12.3 4- 4.3  4.8  +  2.6 
(C57BL/6  ×  C3H)Fa  b/j  NP-BGG  64.4  4- 3.7  51.5  4- 3.8 
NIP-BGG  NT  77.3 ±  10.4 
CFA  7.4 4- 0.8  6.7  :t:  1.7 
(BALB/e ×  C57BL/6)F1  a/b  NP-BGG  39.4  ~  3.8  35.2  ±  4.1 
NIP-BGG  NT  42.4  4- 2.5 
CFA  4.0  zlz 2.7  1.2 ±  3.0 
NT, not tested. 
* Animals were treated with 20 mg/kg cyclophosphamide. 3 d later they were primed subcutaneously in 
two sites with a  total of 100 gtg NP-BGG or NIP-BGG in CFA. 7 d  after priming, the animals were 
challenged with the appropriate challenge antigen. Swelling of challenge foot compared with control foot 
was measured 24 h after challenge. 
Responses of a minimum of four animals per group in 10  -4 inches. Expressed  as mean +  1 SE. 
In  addition,  NIP-specific DTH  responses  can  be  induced  in  each  of these  strains  of 
mice if they are primed with NIP-BGG  (Table I). 
Fine Specificity of the  DTH Response Induced with NP.  In  view  of the  heteroelitic 
antibody  responses to NP  in appropriate  strains of mice, the ability of various strains 
carrying the Igl b allotype to demonstrate  cross-reactive DTH  responses  to NIP, after 
NP  priming,  was  tested.  As indicated  in Table  I, C57BL/6  and  B10.A mice primed 
with  100  /tg  of  NP-BGG  produce  DTH  responses  after  challenge  with  NP-BSA. 
However, the DTH  reactions in these strains are highly cross-reactive with NIP-BSA. 
The  magnitude  of  the  cross-reactive  NIP  responses  were  comparable  to  the  NP 
responses.  As indicated  above, A/J,  C3H,  BALB/c,  and  CBA(M523)  strain  mice do 
not  produce  a  significant  cross-reactive  NIP  response  when  they  have  been  primed 
with NP. This is not a  result of an inability to respond to NIP; thus, A/J, CBA(M523), 
BALB/c,  and  C3H  mice  make  significant  NIP  DTH  responses  to  NIP-BSA  when 
primed  with NIP-BGG.  The  difference in the specificity of the DTH  response to NP 
are not controlled by genes  in  the MHC  region, because  B10.A and  A/J  mice share 
the  H-2  a  haplotype,  yet  differ  in  their  ability  to  cross  react  with  NIP.  The  data 1340  GENETIC  CONTROL  OF  DELAYED-TYPE  HYPERSENSITIVITY 
TABLE II 
Cell Transfer of NP-Specific DTH in C57BL/6 Mice* 
Donor cells  Treatment 
DTH challenge 
NP-BSA  NIP-BSA 
NP immune  --  48.0  +  7.9:~  49.7  +  9.3 
control  --  5.5  +  3.4  2.3  +  2.3 
NP immune  NMS  +  C  31.0  +  8.0  NT 
NP immune  Anti-Thy 1.2  +  C  7.3  -'r  2.6  NT 
NT, not tested. 
* Immune C57BL/6 donor animals were pretreated with cyclophosphamide 3 d  before priming with NP- 
BGG in CFA. 7 d after priming 2 X  10  7 draining lymph node cells were transferred i.v. to naive syngeneic 
recipients.  Control  mice  received  a  mixture of 2  X  107  lymph node  and  spleen cells  obtained  from 
C57BL/6 mice which had received cyclophosphamide 3 d before immunization with CFA. 
Arithmetic mean :t=  1 SE of groups consisting of four or more animals. Expressed in units of 10  -4 inches. 
presented in Table I also demonstrate that F1 hybrids between a strain which cross- 
reacts  to  NIP  and  strains  which  do  not  exhibit  the  NIP  cross-reactivity, namely 
(C57BL/6  X  C3H)F1  and  (BALB/c  ×  C57BL/6)F1 hybrids, exhibited significant 
cross-reactive NIP responses after NP priming. Thus, the NIP cross-reactivity in DTH 
responses is the dominant phenotype in the F1 combinations tested. 
Cellular  Requirements for  Transfer  of DTH.  The  next  series  of experiments  were 
performed to demonstrate that the responsiveness to NP compounds was transferable 
and T-cell dependent  (Table II).  In  the first experiment, 2  X  107  draining lymph 
node cells from cyclophosphamide pretreated, NP-BGG-primed animals were trans- 
ferred intravenously to naive syngeneic recipients. Control animals received a transfer 
of lymphoid  cells  from  cyclophosphamide pretreated,  CFA-primed  animals.  Only 
those animals which received lymphoid cells from NP-primed animals showed signif- 
icant  reactivity to  challenge  with  NP-BSA.  Furthermore,  the  cross-reactive DTH 
response to NIP, noted in B6 mice, was transferable with NP-immune cells (Table II). 
Thus, lymph node cells are sufficient to transfer this DTH reactivity. 
The second experiment was carried out to investigate the T-cell dependence of the 
ability to transfer the delayed hypersensitivity reaction. Accordingly, 2  X  10  s NP 
immune lymph node cells were treated with either normal mouse serum plus comple- 
ment or anti-Thy 1.2 antiserum plus complement, before transfer to naive syngeneic 
hosts. The number of cells recovered after treatment were only sufficient to transfer 
and check reactivity with NP-BSA. As seen in Table II, anti-Thy 1.2 plus complement 
treatment significantly (P <  0.05)  diminished NP responses to levels comparable to 
the background reactivities seen in naive animals. Thus removal of T  cells abrogates 
ability of immune lymph node cells to tranfer DTH reactivity. 
Genetic Mapping of NP Cross-Reactivity on DTH.  To map the genes responsible for 
the strain differences seen in the ability of NP-immune mice to respond to the cross- 
reactive NIP hapten,  mice congeneic for the immunoglobulin  heavy-chain linkage 
group were used  (Table III).  BALB/c mice have heavy-chain constant  region and 
heavy-chain variable region markers of the Igl a allotype. C.B-20 is congeneic at these 
loci with BALB/c, and expresses the Igl b constant heavy chain and variable heavy- 
chain markers derived from the C57BL/Ka strain (14). The data indicates the BALB/ 
c NP primed mice do not make cross-reactive NIP responses, whereas C.B-20 mice do. 
Thus, genes in the heavy-chain linkage group control ability to cross-react to NIP. WEINBERGER  ET  AL. 
TABLE III 
Genetics of NP Cross-Reactivity with NIP in DTH Responses* 
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Heavy-chain haplo-  DTH challenge 
Strain  type  Immunogen 
CH  VH  NP-BSA*  NIP-BSA 
BALB/c  a  a  NP-BGG  68.5 ±  7.2  5.5 +  3.3 
NIP-BGG  NT  60.5 3= 2.5 
CFA  8.0 ±  5.4  5.5 ±  3.7 
C.B-20  b  b  NP-BGG  45.6 ±  3.0  52.5 ±  4.8 
CFA  -4.0 ±  4.0  8.0 ±  2.0 
BAB/14  b  a  NP-BGG  48.8 ±  6.0  2.5 3= 2.6 
NIP-BGG  NT  41.5 ±  6.4 
CFA  6.0 ±  3.3  3.0 ±  2.5 
SJL  b  b  NP-BGG  59.0 ±  2.0  54.8 3=  1.4 
NIP-BGG  NT  54.5 ±  5.8 
CFA  8.0 ±  2.0  5.0 ±  1.7 
NT, not tested. 
* Animals were treated with 20 mg/kg cyciophosphamide. 3 d later they were primed subcutaneously in 
two sites with a total of 100 #g NP-BGG or NIP-BGG  in CFA.  7 d after priming,  the animals were 
challenged with the appropriate challenge antigen. Swelling of challenge foot compared with control foot 
was measured 24 h after challenge. 
Responses of a minimum of four animals per group in 10  -4 inches. Expressed as mean  3=  1 SE. 
In an effort to determine whether genes in the VH- or Cn-genetic regions control 
this trait, another congeneic strain, BAB/14, was examined. The BAB/14 mice carry 
a  recombinant  heavy-chain linkage group. The CH genes are derived from  the Igl b 
linkage  group,  and  most  of the  VH  genes  are  derived  from  the  BALB/c  parent, 
including genes coding for the NP  idiotype in this strain  (15,  7).  It was  found  that 
mice from this strain do not  make a  significant cross-reactive response to NIP, with 
only NP priming. This indicates that Vn-region genes exert control over the expression 
of the ability to make cross-reactive NIP DTH  responses. 
Finally, mice of the SJL strain were studied. As indicated in the introduction, these 
mice do not make heteroclitic antibody despite having the proper Cn-linkage group. 
In the DTH  assay, however,  it was found  that  SJL mice do make significant cross- 
reactive NIP responses when primed with NP-BGG. 
Genetic Restriction on  Transfer of NP-Specific  DTH.  To  investigate  the  role  of the 
MHC  in the ability to transfer delayed hypersensitivity to NP, a  series of allogeneic 
transfer experiments were performed. Donor mice were cyclophosphamide pretreated 
and primed subcutaneously  in four sites with  200 #g NP-BGG in CFA.  7 d  later, 3 
×  107  draining lymph  node  cells were  transferred  intravenously  into  recipients of 
various mouse  strains.  1 h  after transfer,  the recipient mice were  challenged  in the 
footpad with either NP-BSA or NIP-BSA. Swelling was measured 24 h after challenge 
(Table IV). 
Lymphoid cells from C57BL/6 mice sensitized to NP transferred reactivity to both 
NP  and  NIP,  when  transferred  into  H-2-identical hosts,  C57BL/10,  or  into  semi- 
allogeneic hosts,  (C57BL/6  X  C3H)F1. On the other hand,  transfer to a  completely 
H-2 nonidentical host, B 10.BR, was unsuccessful. The reciprocal experiment, namely 
B10.BR  transfer, was successful into syngeneic and  (C57BL/6  ×  C3H)FI mice. The 
immune B10.BR  lymphoid cells were incapable of transferring DTH  reactivity to a 1342  GENETIC  CONTROL  OF DELAYED-TYPE  HYPERSENSITIVITY 
TABLE IV 
Ability of NP-Primed Cells to Transfer  DTH Reactivity to Different Strains of Mice* 
Donors of immune cells transferred 
H-2-region formulae 
Recipient  (K,IA,IB,IJ,IE,IC,S,D)  C57BL/6:I:  B 10.BR:I: 
NP-BSA§  NIP-BSA  NP-BSA  NIP-BSA 
C57BL/10  b,h,b,b,b,b,b,b  51.6 :t: 6.3 ti  47.7 ±  10.4 II  7.9 ±  2.4  5.2 :t: 4.3 
(C57BL/6  ×  b,b,b,b,b,b,b,b 
57.6 :!: 6.5 II  62.5 ±  4.9 II  43.3 ±  6.5 II  53.7  ±  7.0 II  C3H)F1  k,k,k,k,k,k,k,k 
B10.BR  k,k,k,k,k,k,k,k  10.6 ±  5.0  5.5 ±  4.4  31.9 ±  4.6 II  22.0  ±  5.5 II 
B10.A(4R)  k,k,b,b,b,b,b,b  15.0 ±  5.2  5.5 ±  3.7  48.0 ±  5.611  46.9  ±  9.0 II 
B 10.4(5R)  b,b,b,k,k,d,d,d  53.1  ±  6.9 II  60.0 ±  4. I II  NT  NT 
CBA(M523)  ka,k,k,k,k,k,k,k  NT  NT  52.5 ±  7.0 II  47.6  ±  7.2 II 
NT, not tested. 
* Donor animals were treated with cyclophosphamide and 3 d later injected subcutaneously with a total 
of 200 #g NP-BGG in a 0.4-ml 50% CFA solution, in four separate sites. 7 d after priming,  3  ×  107 
draining lymph node cells were transferred to naive recipient animals. The recipients were challenged  1 
h after transfer. 
§ Minimum of four recipients per group. Arithmetic mean  ±  SE. Units of 10  -4 inches. 
:~ Backgrounds for each of the above strains using transfer of cyclophosphamide pretreated, CFA-primed 
donors  of lymph  node  and  spleen  cells were:  C57BL/6-NP-background  response 8.4  ±  4.8, NIP- 
background response 13.8 ±  5.1; B10.BR-NP-background response 4.8 ±  1.5, NiP-background response 
8.2  ±  3.3. 
II v < O.Ol. 
congeneic  H-2  nonidentical host,  C57BL/10.  In addition,  (B6  ×  A)Fx NP-immune 
cells could transfer DTH  reactivity to C57BL/6  parental strain mice; thus the cells 
were not simply rejected (data not shown). Thus, ability to transfer NP-specific DTH 
is MHC  linked. 
To  map  the genetic subregion  of the  MHC  which  controls successful  transfer  of 
DTH, several mouse strains with recombinant or mutant MHC  regions were examined 
with respect to their ability to successfully mount a  response using the transferred cell 
populations. When C57BL/6  (H-2  b)  NP-immune lymph node cells were transferred 
into B10.A(4R)  (kkbbbbbb) mice which share the I-B, I-J, I-E, I-C, S, and D  regions 
with  the donor C57BL/6  strain,  no  transfer  of NP  reactivity was  noted.  However, 
when  the same cells were transferred into B10.A(5R)  mice (bbbkkddd), which share 
the  K,  I-A,  and  I-B  regions  with  the  B10  donor  strain,  successful  transfer  of NP 
reactivity was achieved. Similar results demonstrating that genes in the K  and/or I-A 
were required for successful transfer were obtained using different strain combinations. 
Thus,  immune  BI0.BR  (H-2  k)  lymphoid cells  transferred  NP-specific reactivity to 
B10.A(4R).  The  ability of immune  B10.BR  lymphoid cells to transfer immunity  to 
the CBA(M523)  mice, which possess a  mutant  H-2K allele, indicates that identity at 
H-2K is not required for transfer of NP DTH  reactivity. Furthermore, the ability to 
transfer  immunity  to  the  CBA(M323)  strain  which  also  differs  from  the  B10.BR 
donor  strain  at  numerous  non-H-2  loci,  including  the  CH  and  VH  loci,  indicates 
homology for these loci is not required for transfer of NP DTH  reactivity. In all cases 
in  which  NP  reactivity was successfully transferred, concomitant  cross-reactivity to 
challenge with NIP in the recipient was noted. 
Discussion 
Specific DTH  responses to the NP  and  NIP haptens  could be induced in  various 
strains of mice after cyclophosphamide pretreatment  and immunization with NP or WEINBERGER ET AL.  1343 
NIP conjugated to bovine gamma globulin. Evidence for the existence of hapten- 
specific T cells has been found in other systems. Yamashita and Kitagawa (16) found 
that dinitrophenyl-mouse gamma globulin (DNP-MGG)-immunized mice developed 
T-helper cells which provided help in response  to DNP-keyhole limpet hemocyanin 
and that p-azobenzoate (PABA)-BGG-immunized mice developed radioresistant T 
cells capable of cooperating with DNP-primed B cells in response  to DNP-MGG- 
PABA  (16). Hamaoka et al.  (17) demonstrated that  PABA-specific  helper T  cells 
could be tolerized by PABA-copolymer of D glutamic acid and D-lysine. Cosenza et al. 
(3) were able to prime PC-specific  helper T cells by pretreating the donor with anti- 
idiotypic antibodies. Thus hapten-specific helper T-cell  function has been  demon- 
strated in several systems. 
The use of  cyclophosphamide  in the induction of  the hapten-specific DTH responses 
described  above  was  motivated by  the  following considerations.  The  differential 
sensitivity of B cells and suppressor T cells to cyclophosphamide treatment have been 
documented (18-21).  In addition, Askenase et al.  (20) have shown an augmentation 
of DTH responses by low doses of cyclophosphamide. The NP-specific DTH response 
was a classical DTH reaction, characterized by edema, induration, and a mononuclear 
cell  infiltrate. Futhermore, the time course of the response  was consistent with a 
classical  DTH reaction; swelling was not detectable until  12-16  h  after challenge, 
and  reached  its  maximal magnitude at  20-36  h.  Finally, the immunity could be 
adoptively transferred by lymphoid cells, was T-cell dependent, and MHC restricted. 
The NP system was chosen for analysis, because the genetics of the fine specificity 
of the antibody response have been well documented (6-10). Furthermore, Krawinkel 
et al.  (11) demonstrated that a  putative receptor material demonstrating the same 
fine specificity as anti-NP antibody could be isolated from enriched populations of T 
cells. Because  the question of which functional subpopulations of T  cells bore this 
receptor remained unresolved, the present experiments were initiated. The present 
data demonstrate that a gene(s) coded for by the Vn-region controls the fine specificity 
of the DTH response, and suggest that at least one T-cell population involved in the 
DTH response bears a VH-coded receptor. In strains lacking the Igl  b allotype, priming 
with NP-BGG induced a hapten-specific DTH response to a challenge of NP coupled 
to a different carrier, BSA. That this response  was NP specific, and not a result of a 
cross-reactivity between BGG and BSA proteins used for priming and challenge, was 
demonstrated by the  inability of NIP-BSA  to elicit  a  DTH  response  in similarly 
primed animals. Furthermore, we demonstrated that animals primed with NIP-BGG 
could give a  NIP DTH response  when challenged with NIP-BSA.  In those strains 
possessing  the Igl  b heavy-chain linkage group,  such  as  the  C57BL/6  and  BI0.A 
strains,  the fine specificity of the NP-primed  DTH  response  was clearly different. 
Thus, NP-primed C57BL/6 or B10.A  mice primed with NP-BGG and challenged 
with NIP-BSA, developed DTH reactions with almost the same magnitude as similarly 
primed animals responding to NP-BSA.  In addition, the fine specificity  of DTH- 
reactivity pattern of (NIP cross-reactive  ×  noncross-reactive)F1  hybrids (C57BL/6 
X  C3H)F1  and (BALB/e  ×  C57BL/6)Fi were like those of the NIP cross-reactive 
C57BL/6 parental mice. Thus, ability to respond cross-reactively to NIP was inherited 
in a dominant or codominant fashion. It should be noted that the conditions used to 
observe  hapten-specific DTH responses  had been optimized in the present study to 
demonstrate  maximal  DTH  reactivity.  Under  more  limiting conditions,  such  as 
observation at 36-48 h after DTH challenge, the cross-reactive NIP response appeared 1344  GENETIC CONTROL OF DELAYED-TYPE HYPERSENSITIVITY 
larger and more consistent than the response to the homologous NP hapten (data not 
shown).  Thus,  we  should  term  the  NP-induced  NIP  cross-reactive DTH  response, 
heteroclitic. 
A detailed genetic study of the control of the NIP cross-reactive or heteroclitic fine- 
specificity characteristics was undertaken. From the data presented in Tables I  and 
III, in which MHC-identical mouse strains, such as B10.A and A/J or BALB/c and 
C.B-20 demonstrated different DTH fine-specificity patterns, it was concluded that 
genes in the MHC did not control the expression of DTH-heteroclitic NP responses. 
The BALB/c and C.B-20 are congeneic with respect to the heavy-chain linkage group. 
BALB/c  mice  express  the  Igl a  allotype,  whereas  C.B-20,  which  are  theoretically 
identical with  respect  to other background genes, express Igl b genes in  the heavy- 
chain linkage group. It was found that C.B-20 mice make heteroclitic DTH responses 
to NP, whereas BALB/c mice were unable to do so. These data with congeneic mice 
confirm the strain-distribution  data and  indicate that  a  gene linked  to the heavy- 
chain linkage group controls expression of the heterocliticity of DTH responses to NP. 
To  more  precisely  localize  the  gene(s)  responsible  for  the  ability  to  make  such 
heteroclitic responses, the BALB/c congeneic, BAB/14 strain, which carries a recom- 
binant haplotype in which crossing over occurred between the Cn genes derived from 
Igl b and the Vn genes derived from the Igl a allele of the BALB/c parent, were tested. 
At the humoral level, BAB/14 mice do not express the VnNP  b gene, and, thus, do not 
produce heteroclitic antibody responses  (7,  8).  In  the  DTH assay described above, 
BAB/14 mice, when primed with NP, also failed to cross-reactively respond to NIP, 
and thus were not heteroclitic. The data, therefore, indicate a gene in the VH-region 
controls the expression of the heteroclitic DTH, T-cell dependent, response. 
The presence of Vn-region products has been described in other systems (1-5). Vn- 
region products have been identified indirectly on T-helper cells (22, 23), alloreactive 
T  cells (24), and T-cell derived suppressor (25, 26) and helper (27, 28) factors. In these 
studies, similar VH-region products were also found on immunoglobulins of the same 
specificity. This study identifies VH-gene expression on a  functional class of T  cells 
without the aid of serological reagents. Moreover, genetic mapping of the Vn-region 
markers  of  the  heteroclitic  T-cell  DTH  response  is  to  the  same  region  as  the 
immunoglobulin produced in the primary heteroclitic anti-NP response. The simplest 
explanation for this is that the T  and B cell express some VH-region products coded 
for by  the  same  gene(s),  in  their  respective anti-NP  response.  Thus,  the  evidence 
presented indicates that at least one T cell in the DTH pathway for anti-NP responses 
has a Vn-coded receptor, sharing fine-specificity  characteristics with the B-cell receptor 
for the same specificity. 
The expression of the heteroclitic fine specificity patterns is not absolutely identical 
at  the T- and  B-cell levels. The one exception note was  the response of SJL mice 
which was particularly informative. SJL mice fail to produce heteroclitic antibody in 
response to NP, despite the fact that  this strain bears the Iglb-linkage group (7, 8). 
SJL mice also produce very low levels of X-light chains (29). It has been postulated 
that production of adequate levels of h-chains is necessary for expression of the gene- 
controlling heteroclitic anti-NP antibody (7, 8). The fact that SJL mice do have the 
gene  which  controls  heteroclicity,  VnNP  b,  is  indicated  by  studies  showing  that 
(BALB/c  x  SJL)F1 (7) and  (CBA  X  SJL)F1 (8) hybrid mice (hybrids between SJL 
mice and mice of strains with non-Igl b heavy-chain linkage groups) make heteroclitic WEINBERGER  ET  AL.  1345 
primary  anti-NP  antibody  responses.  This  is  presumably  a  consequence  of the 
functional complementation between the VHNP  b gene of the SJL and the functioning 
X-chain production mechanism contributed by the other parent. When the SJL strain 
was tested in the DTH assay, it was found that  SJL mice made cross-reactive NP- 
induced DTH responses (Table III). Thus, SJL strain mice express the V-gene marker 
for T-cell heteroclicity. Several conclusions are implied.  First, because SJL mice do 
not express heteroclitic anti-NP  antibody, but  do make heteroclitic T-cell anti-NP 
DTH  responses,  heteroclitic DTH  T  cells  probably produce  their own  functional 
antigen-specific receptor. Second, the results of the SJL strain implies that either T 
cells can endogenously produce ~t-light  chains for use in making a  heteroclitic T-cell 
receptor, or T  cells do not make use of a )t-light chain in construction of a heteroclitic 
T-cell receptor. 
MHC  restriction on T-cell function has  been demonstrated for cytotoxic T  cells 
(30-33), DTH-reactive cells  (34, 35), and  for T-cell-B-cell collaboration  (36).  In an 
effort to demonstrate similar MHC restriction on the population of NP-specific DTH- 
reactive T  cells, a series of acute adoptive transfer experiments were performed. The 
first point of note was that whenever NP reactivity was successfully transferred from 
an NP-primed DTH-heteroclitic strain, a simultaneous transfer of NIP cross-reactivity 
occurred.  Second,  K-  and  I-A-region  homology between  donor and  recipient  was 
sufficient  to  allow  transfer  of DTH  reactivity.  This  was  shown  by  the  ability  of 
C57BL/6  cells  to  transfer  DTH  reactivity  to  B10.A(5R),  but  not  to  B10.A(4R). 
B10.A(4R) is homologous with C57BL/6 across the H-2 complex, except at K  and I- 
A,  whereas  B10.A(5R)  is  H-2  homologous with  C57BL/6  at  the  K,  I-A,  and  I-B 
regions. In addition, it appears that the I-A region may be critically involved because 
disparity at H-2K was not sufficient to prevent transfer of NP-specific DTH reactivity 
from B10.BR to CBA(M523)  (although we must  be cautious when using an H-2K 
mutant  to define disparity),  It  is  also  remarkable  that  this  transfer was  successful 
despite  the disparate  background  genes,  including CH and  Vrl,  of the recipient as 
compared with the donor. These results imply that homology at  (a) K  and I-A or D 
and I-A, or (b) I-A alone are sufficient to allow DTH transfer of NP reactivity, and 
that  homology at other loci, including CH- and  Vn-region genes,  are not required. 
These findings are in accord with the conclusions of Miller et al. (34) who previously 
demonstrated that, for protein antigens, DTH reactivity could be transferrred between 
I-A-subregion homologous strains of mice. 
Moreover,  these  experiments  demonstrate  that  the  functional  specificity of the 
primed NP-specific DTH T-cell population is controlled by genes mapping in the VH 
and H-2 complexes. There are at least two likely possibilities explaining the apparent 
dual recognition by the T  cell of NP-haptenic determinants and H-2-coded determi- 
nants. One explanation would be that different T-cell populations separately express 
the antigen  reactivity controlled by gene products of the VHNP  b gene, and  MHC 
restriction. These two cell types would have to communicate with each other to evoke 
a  DTH  response.  This,  however,  is  an  unlikely  possibility  on  the  basis  of  the 
accumulated  evidence in  other T-cell responses  (37).  The second  major and  more 
likely possibility to explain the described phenomenon is that there are T  cells in the 
primed T-cell population which express, simultaneously, VHNP  b gene products and, 
independently,  express  MHC  restriction.  The  data  are  most  consistent  with  two 
binding sites for DTH-specific T  cells in this system. Whether such cells have one or 1346  GENETIC CONTROL OF DELAYED-TYPE HYPERSENSITIVITY 
two structures on their surface for identifying the two specificities, cannot be definitely 
concluded from currently available data.  These studies were aimed at defining the 
genetic control of the heteroclitic DTH T-cell response,  and  its  MHC  restriction. 
Whether similar heteroelitic specificity can be seen in other T-cell functional responses 
to NP, such as T-dependent help, suppression or cytolysis, remains to be investigated. 
Summary 
Hapten-specifie delayed-type hypersensitivity (DTH) was induced in several strains 
of mice. (4-hydroxy-3-nitrophenyl)acetyl-bovine  gamma globulin (NP-BGG)-primed 
mice which did not bear the Igl b heavy-chain linkage group made a NP-specifie DTH 
response when challenged with NP bovine serum albumin (BSA) and failed to respond 
to  challenge  with  (4-hydroxy-5-iodo-3-nitrophenyl)acetyl-bovine serum  albumin 
(NIP-BSA).  Strains  of NP-BGG-primed  mice bearing the  Igl b allotype, including 
SJL, responded to challenges of either NP-BSA or NIP-BSA.  F1 hybrids between a 
cross-reactive strain,  C57BL/6, and  two other noncross-reactive strains  were cross- 
reactive. 
Genetic mapping of the NIP-cross-reactive DTH response localized the trait to the 
Vn-region of the Igl b heavy-chain linkage group. The fine-specificity pattern of the 
T-cell anti-NP response, and the genetic mapping of this trait, were analogous to the 
reported  fine  specificity  and  mapping  data  of the  humoral  heteroclitic  anti-NP 
response. 
Adoptive  transfer  studies  on  the  ability  to  transfer  NP-specific  DTH  between 
various strain  combinations showed that  the T-cell donors and  the recipient must 
have homology for at least the I-A subregion. Whenever NP-specific reactivity was 
transferred from a strain which cross-reactively responded to NIP, the recipient also 
responded to both NP and NIP. The implications of the control of NP-primed DTH- 
reactive populations of T  cells by two distinct  genetic regions, Vn  and  H-2, were 
discussed. 
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